☆ 4.7 Article

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required

JOURNAL OF CLINICAL MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

Philip A. Mudd et al.

Summary: SARS-CoV-2 mRNA vaccines induce potent immune responses, including antibodies and CD4(+) T cell responses. Research has found that vaccine-induced follicular helper CD4(+) T cell responses play a key role in establishing long-term immunity.

CELL (2022)

Add to Collection

Article Medicine, General & Internal

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Lisa M. Dunkle et al.

Summary: The NVX-CoV2373 vaccine has shown to be safe and highly effective in preventing Covid-19, with a vaccine efficacy of 90.4% against reverse-transcriptase-polymerase-chain-reaction-confirmed cases and 100% efficacy against moderate-to-severe disease. The vaccine also demonstrated high efficacy against various variants of the virus.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection

Martina Patone et al.

Summary: Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to concerns in regulatory, clinical, and public health sectors. A self-controlled case series study in England showed an increased risk of rare neurological complications following COVID-19 vaccination and infection. The study highlighted a higher risk of Guillain-Barre syndrome after ChAdOx1nCoV-19 vaccination.

NATURE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review

Pedram Keshavarz et al.

Summary: This study reviewed cases of lymphadenopathy (LAP) associated with COVID-19 vaccination, finding that the majority of LAP cases occurred within the first day to 4 weeks after vaccination, with only two cases showing residual findings at 5 and 6 weeks after first and second dosages.

ACADEMIC RADIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

Anders Husby et al.

Summary: This study investigated the association between SARS-CoV-2 vaccination and myocarditis or myopericarditis, finding an increased risk of developing these conditions within 0-28 days post-vaccination, especially among individuals aged 12-39 and males.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Letter Allergy

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine

Priya Sellaturay et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Add to Collection

Article Medicine, General & Internal

Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report

Serge Goldman et al.

Summary: Nucleoside-modified mRNA vaccines have a strong impact on T follicular helper cells, which may influence the development of neoplasms. This report discusses the unexpected rapid progression of lymphomatous lesions in a man diagnosed with AITL after receiving a BNT162b2 mRNA vaccine booster.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Letter Oncology

Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination

Caitlin M. Brumfiel et al.

LEUKEMIA & LYMPHOMA (2021)

Add to Collection

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Dermatology

Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination

T. Gambichler et al.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Review Immunology

Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection

Dawei Cui et al.

Summary: Tfh cells play a central role in controlling SARS-CoV-2 infection by eliciting neutralizing antibody production, but further studies are needed to elucidate the effector mechanisms mediated by Tfh cells in anti-SARS-CoV-2 immunity.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Health Care Sciences & Services

Shaping EU medicines regulation in the post COVID-19 era

Marco Cavaleri et al.

Summary: The EU Medicines Regulatory Network played a crucial role in the COVID-19 crisis, providing valuable lessons that will shape future medicines regulation.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Follicular helper T cells in type 1 diabetes

Feng Shao et al.

FASEB JOURNAL (2020)

Add to Collection

Review Oncology

Advances in understanding of angioimmunoblastic T-cell lymphoma

Shigeru Chiba et al.

LEUKEMIA (2020)

Add to Collection

Editorial Material Endocrinology & Metabolism

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the UK

Rebecca Unsworth et al.

DIABETES CARE (2020)

Add to Collection

Article Oncology

RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis

Jose R. Cortes et al.

CANCER CELL (2018)

Add to Collection

Article Immunology

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Norbert Pardi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Add to Collection

Article Endocrinology & Metabolism

Circulating CXCR5+PD-1+ICOS+ Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies

Tyyne Viisanen et al.

DIABETES (2017)

Add to Collection

Review Immunology

The good, the bad and the ugly - TFH cells in human health and disease

Stuart G. Tangye et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.